Moderna and Pfizer have previously announced that the updated vaccines would be ready this fall. The FDA’s approval comes amid a steady rise in reported COVID-19 cases and hospitalizations in ...

Pfizer (PFE) shares traded higher Thursday after the U.S. Food & Drug Administration formally approved its coronavirus vaccine for booster shots in older and at risk Americans. The FDA said ...

The FDA and Pfizer had originally proposed approving ... The White House in August signaled that it intended to sanction booster shots for all Americans in the week of Sept. 20.

17, the FDA’s outside advisory committee is due to publicly review Pfizer’s data supporting ... to see more data before encouraging third booster shots for the general population starting ...

The FDA and CDC fully authorized Pfizer’s booster shot in late September ... a “mix and match” approach to COVID vaccine booster shots this week when they give full approval for Moderna ...

For everyone else, there's no new booster recommendation for now, though the FDA and CDC ... moving forward. Pfizer also said it will have a patient assistance program to keep shots free for ...

The Food and Drug Administration has voted to recommend three shots for people who ... Valley Health Network. But the FDA stopped short of recommending the booster for everyone 16 and over.

The findings reinforce advice recommending that those who received the J&J vaccine receive a second booster dose with an mRNA vaccine, the technology used in the Moderna and Pfizer shots ...

5) is already FDA-authorized under an EUA for ... based on clinical data from trials of BA.1 booster shots. Just beforehand, Moderna sued Pfizer/BioNTech for what it claims was patent infringement ...

US pharmaceutical company Pfizer has filed ... Drug Administration (FDA) this week for an emergency clearance to vaccinate children aged 5 to 11 with a 10-microgram booster dose against the ...